Viewing StudyNCT04446416



Ignite Creation Date: 2024-05-06 @ 2:50 PM
Last Modification Date: 2024-10-26 @ 1:38 PM
Study NCT ID: NCT04446416
Status: COMPLETED
Last Update Posted: 2023-09-06
First Post: 2020-06-16

Brief Title: Efficacy and Safety of NaviFUS System add-on Bevacizumab BEV in Recurrent GBM Patients
Sponsor: NaviFUS Corporation
Organization: NaviFUS Corporation

Conditions & Keywords Data

Conditions:
Name
Neoplasms Nerve Tissue
Glioblastoma Multiforme
Glioblastoma
Glioma
Brain Tumor
Neoplasms
Keywords:
Name View
Bevacizumab View
NaviFUS System View
Blood-Brain Barrier View
Focused Ultrasound View
GBM View